A man infected with HIV and hepatitis C through blood products in the 1980s has told of his shock diagnosis as a teen. Speaking anonymously to the Infected Blood Inquiry, he said he and others at a school for disabled children were "left to go and die". More than 120...
An increased number of pre-exposure prophylaxis, or PrEp drugs, are coming to the market to help lower the cost of for patients. However, the lower-cost options are raising questions over a drug pricing program known as 340B, that generates revenue for critical HIV care and resources. Dr. David Rosenthal, the medical director at the Center for Young Adult, Adolescent and Pediatric HIV at Northwell Health Great Neck New York, joins CBSN's Lana Zak with his analysis.
New York City, NYPosted byPOZ
Merely a month after being crowned Miss Universe in 2021 at the 69th annual competition, Andrea Meza is already using of the power of her crown to make a positive impact. To help spotlight National HIV Testing Day on June 27, the former Miss Mexico took a rapid HIV test at GMHC in New York City on June 21. The testing event was organized by the Latino Commission on AIDS, which has been partnering with the Miss Universe Organization for the past 15 years to spread HIV awareness.
Medical & BiotechThe Guardian
“I am a change agent,” declared Emma Walmsley, as she unveiled the biggest overhaul of GlaxoSmithKline in the 20-odd years of the company’s life in its current form. The consumer healthcare division will depart via a plain-vanilla demerger next year; shareholders will have to live with a sharply reduced dividend; and “new GSK” will seek salvation for its rotten share price by investing more heavily in its core business of pharmaceuticals and vaccines.
The tipping point came in 1988. That’s the year new HIV cases among Black people surpassed incidence among white people in the United States, and it’s been that way ever since, according to data from the Centers for Disease Control and Prevention (CDC) published in Morbidity and Mortality Weekly Report.
Researchers in India have conducted a study showing that the seroprevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19) – was lower among people living with HIV and AIDS than among the general population. The team – from the All India...
Alaska StateJuneau Empire
While Alaskans and public health officials concentrated on COVID-19 cases in 2020, syphilis infections increased across the state. According to a bulletin issued by the Department of Health and Social Services this week, “Alaska’s syphilis outbreak continues to grow, and congenital syphilis cases are at a record high.”. “I’m not...
On the 40th anniversary of the HIV/AIDS pandemic this month, a person newly diagnosed with HIV can live a near-normal life expectancy by taking antiviral medication. The tremendous scientific progress means that I now treat some HIV patients with monthly injections and no pills. Yet despite the advances in treatment, there has been insufficient progress in addressing the racial and ethnic disparities of HIV, and the systemic racism that contributes to this.
Diseases & TreatmentsPosted byABC News
This month, the FDA approved a new treatment for Alzheimer’s disease, but doctors are split on whether they would recommend the drug.
In a groundbreaking study, a team of UC Davis researchers has discovered a special type of stem cell that can reduce the amount of the virus causing AIDS, boosting the body's antiviral immunity and repairing and restoring the gut's lymphoid follicles damaged by the simian immunodeficiency virus (SIV), the equivalent of the human immunodeficiency virus (HIV) in non-human primates.
ViiV Healthcare and Halozyme Therapeutics have entered a global partnership and licence agreement to leverage the latter’s ENHANZE drug delivery technology to develop ‘ultra long-acting’ drugs for human immunodeficiency virus (HIV). According to the deal, Halozyme will receive an upfront payment of $40m from ViiV for the exclusive licence to...
HealthPosted byVerywell Health
Moderna's mRNA technology was so effective in its COVID-19 vaccine that the company is using the same approach to develop vaccines against other viruses like flu and HIV. Unlike traditional vaccines, the mRNA technology can build proteins that teach the immune system to recognize a virus — it's more effective against variants.